Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3748)
All Articles published online
|
Aug 14, 2012 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil. World J Gastroenterol 2012; 18(30): 3955-3961 [PMID: 22912546 DOI: 10.3748/wjg.v18.i30.3955] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i30/3955.htm |
| Number | Citing Articles |
| 1 |
Christian Mayr, Tobias Kiesslich, Dominik Paul Modest, Sebastian Stintzing, Matthias Ocker, Daniel Neureiter. Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?. Expert Opinion on Investigational Drugs 2022; 31(2): 221 doi: 10.1080/13543784.2022.2034785
|
| 2 |
José J. G. Marin, Maria Giuseppina Prete, Angela Lamarca, Simona Tavolari, Ana Landa-Magdalena, Giovanni Brandi, Oreste Segatto, Arndt Vogel, Rocío I. R. Macias, Pedro M. Rodrigues, Adelaida La Casta, Joachim Mertens, Cecilia M. P. Rodrigues, Maite G. Fernandez-Barrena, Ana Da Silva Ruivo, Marco Marzioni, Giulia Mentrasti, Pilar Acedo, Patricia Munoz-Garrido, Vincenzo Cardinale, Jesus M. Banales, Juan W. Valle, John Bridgewater, Chiara Braconi. Current and novel therapeutic opportunities for systemic therapy in biliary cancer. British Journal of Cancer 2020; 123(7): 1047 doi: 10.1038/s41416-020-0987-3
|
| 3 |
Saihong Yu, Zhuduo Li, Linglan Tu, Yiyi Pu, Dongmei Yan, Xiaoju Wang, Xiaoliang Zheng, Jie Yu. Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axis. Journal of Physiology and Biochemistry 2022; 78(3): 679 doi: 10.1007/s13105-022-00894-5
|
| 4 |
Jose J.G. Marin, Oscar Briz, Elisa Herraez, Elisa Lozano, Maitane Asensio, Silvia Di Giacomo, Marta R. Romero, Luis M. Osorio-Padilla, Ana I. Santos-Llamas, Maria A. Serrano, Carolina Armengol, Thomas Efferth, Rocio I.R. Macias. Molecular bases of the poor response of liver cancer to chemotherapy. Clinics and Research in Hepatology and Gastroenterology 2018; 42(3): 182 doi: 10.1016/j.clinre.2017.12.006
|
| 5 |
Laura Fouassier, Marco Marzioni, Marta B. Afonso, Steven Dooley, Kevin Gaston, Gianluigi Giannelli, Cecilia M. P. Rodrigues, Elisa Lozano, Serena Mancarella, Oreste Segatto, Javier Vaquero, Jose J. G. Marin, Cédric Coulouarn. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance. Liver International 2019; 39(S1): 43 doi: 10.1111/liv.14102
|
| 6 |
Laura Taddia, Domenico D’Arca, Stefania Ferrari, Chiara Marraccini, Leda Severi, Glauco Ponterini, Yahuda G. Assaraf, Gaetano Marverti, Maria Paola Costi. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance. Drug Resistance Updates 2015; 23: 20 doi: 10.1016/j.drup.2015.10.003
|
| 7 |
NICHAPAVEE NUTTHASIRIKUL, CHARIYA HAHNVAJANAWONG, ANCHALEE TECHASEN, TEMDUANG LIMPAIBOON, CHANVIT LEELAYUWAT, SIRI CHAU-IN, PATCHAREE JEARANAIKOON. Targeting the Δ133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. International Journal of Oncology 2015; 47(6): 2153 doi: 10.3892/ijo.2015.3188
|
| 8 |
Kitti Intuyod, Paula Saavedra-García, Stefania Zona, Chun-Fui Lai, Yannasittha Jiramongkol, Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Shang Yao, Jay-Sze Yong, Sasanan Trakansuebkul, Sakda Waraasawapati, Vor Luvira, Sopit Wongkham, Somchai Pinlaor, Eric W.-F. Lam. RETRACTED ARTICLE: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance. Cell Death & Disease 2018; 9(12) doi: 10.1038/s41419-018-1235-0
|
| 9 |
Jose J. G. Marin, Paula Sanchon-Sanchez, Candela Cives-Losada, Sofía del Carmen, Jesús M. González-Santiago, Maria J. Monte, Rocio I. R. Macias. Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance. Cancers 2021; 13(10): 2358 doi: 10.3390/cancers13102358
|
| 10 |
Massimiliano Cadamuro, Simone Brivio, Carlo Spirli, Ruth Joplin, Mario Strazzabosco, Luca Fabris. Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma. International Journal of Molecular Sciences 2017; 18(1): 149 doi: 10.3390/ijms18010149
|
| 11 |
Molin Wongwattanakul, Chariya Hahnvajanawong, Wunchana Seubwai, Chanvit Leelayuwat, Temduang Limpaiboon, Patcharee Jearanaikoon. Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopy. Journal of Molecular Structure 2018; 1166: 416 doi: 10.1016/j.molstruc.2018.04.044
|
| 12 |
Qingfan Zheng, Bin Zhang, Changfeng Li, Xuewen Zhang. Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.850732
|
| 13 |
Keiichi Akahoshi, Daisuke Ban, Ryo Kuboki, Atsushi Oba, Hiroaki Ono, Yusuke Mitsunori, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe. Orotate phosphoribosyltransferase as a predictor of benefit from S‐1 adjuvant chemotherapy for cholangiocarcinoma patients. Journal of Gastroenterology and Hepatology 2019; 34(6): 1108 doi: 10.1111/jgh.14477
|
| 14 |
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 261 doi: 10.1038/nrgastro.2016.51
|
| 15 |
Shenli Zhang, Iain B. Tan, Nur S. Sapari, Heike I. Grabsch, Alicia Okines, Elizabeth C. Smyth, Toru Aoyama, Lindsay C. Hewitt, Imran Inam, Dan Bottomley, Matthew Nankivell, Sally P. Stenning, David Cunningham, Andrew Wotherspoon, Akira Tsuburaya, Takaki Yoshikawa, Richie Soong, Patrick Tan. Technical Reproducibility of Single-Nucleotide and Size-Based DNA Biomarker Assessment Using DNA Extracted from Formalin-Fixed, Paraffin-Embedded Tissues. The Journal of Molecular Diagnostics 2015; 17(3): 242 doi: 10.1016/j.jmoldx.2014.12.001
|
| 16 |
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2020; 17(9): 557 doi: 10.1038/s41575-020-0310-z
|
| 17 |
Rocio I.R. Macias, Jesus M. Banales, Bruno Sangro, Jordi Muntané, Matias A. Avila, Elisa Lozano, Maria J. Perugorria, Francisco J. Padillo, Luis Bujanda, Jose J.G. Marin. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1468 doi: 10.1016/j.bbadis.2017.08.002
|
| 18 |
Jose J.G. Marin, Elisa Lozano, Elisa Herraez, Maitane Asensio, Silvia Di Giacomo, Marta R. Romero, Oscar Briz, Maria A. Serrano, Thomas Efferth, Rocio I.R. Macias. Chemoresistance and chemosensitization in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1444 doi: 10.1016/j.bbadis.2017.06.005
|
| 19 |
Molin Wongwattanakul, Chariya Hahnvajanawong, Patcharaporn Tippayawat, Sirinart Chio‐Srichan, Chanvit Leelayuwat, Temduang Limpaiboon, Patcharee Jearanaikoon, Philip Heraud. Classification of Gemcitabine resistant Cholangiocarcinoma cell lines using synchrotron FTIR microspectroscopy. Journal of Biophotonics 2017; 10(3): 367 doi: 10.1002/jbio.201500253
|
| 20 |
Somphon Roeksomtawin, Panida Navasumrit, Somchamai Waraprasit, Varabhorn Parnlob, Thaniya Sricharunrat, Vajarabhongsa Bhudhisawasdi, Niramol Savaraj, Mathuros Ruchirawat. Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell lines. Oncology Letters 2018; doi: 10.3892/ol.2018.8807
|